ORG Wealth Partners LLC Cuts Stock Position in Colgate-Palmolive (NYSE:CL)

ORG Wealth Partners LLC lessened its holdings in Colgate-Palmolive (NYSE:CLFree Report) by 5.6% during the 4th quarter, HoldingsChannel reports. The firm owned 3,854 shares of the company’s stock after selling 227 shares during the period. ORG Wealth Partners LLC’s holdings in Colgate-Palmolive were worth $350,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of CL. Hilltop National Bank raised its position in shares of Colgate-Palmolive by 22.3% during the 4th quarter. Hilltop National Bank now owns 2,409 shares of the company’s stock valued at $219,000 after buying an additional 440 shares in the last quarter. Northcape Capital Pty Ltd raised its position in Colgate-Palmolive by 4.9% during the fourth quarter. Northcape Capital Pty Ltd now owns 6,012 shares of the company’s stock valued at $547,000 after purchasing an additional 282 shares during the period. Range Financial Group LLC raised its position in Colgate-Palmolive by 117.8% during the fourth quarter. Range Financial Group LLC now owns 10,436 shares of the company’s stock valued at $949,000 after purchasing an additional 5,644 shares during the period. Bath Savings Trust Co boosted its holdings in shares of Colgate-Palmolive by 2.9% in the 4th quarter. Bath Savings Trust Co now owns 58,137 shares of the company’s stock worth $5,285,000 after purchasing an additional 1,655 shares during the period. Finally, Diversified Trust Co increased its position in shares of Colgate-Palmolive by 2.6% during the 4th quarter. Diversified Trust Co now owns 83,360 shares of the company’s stock valued at $7,578,000 after purchasing an additional 2,125 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Analyst Ratings Changes

Several research analysts have commented on the stock. StockNews.com lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday. Wells Fargo & Company cut their price target on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a report on Tuesday. Stifel Nicolaus downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $105.00 to $101.00 in a research note on Monday, October 28th. TD Cowen reduced their price target on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a report on Wednesday. Finally, Piper Sandler cut their price objective on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $103.63.

Read Our Latest Analysis on Colgate-Palmolive

Colgate-Palmolive Stock Performance

NYSE:CL traded down $1.34 during trading hours on Friday, hitting $86.12. 1,846,442 shares of the company were exchanged, compared to its average volume of 3,997,147. The stock has a market capitalization of $70.36 billion, a price-to-earnings ratio of 24.68, a PEG ratio of 3.31 and a beta of 0.44. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. Colgate-Palmolive has a 52-week low of $79.69 and a 52-week high of $109.30. The company’s 50 day moving average price is $92.76 and its 200-day moving average price is $98.15.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.32%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is presently 57.31%.

Insider Buying and Selling

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 0.34% of the company’s stock.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Further Reading

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.